Federal appeals court orders access to contraceptive, WSJ reports


The U.S. Second Circuit Court of Appeals in New York said the FDA must make an older version of the Plan B emergency contraceptive available to all ages without a prescription while the issue continues to move through the courts, reports the Wall Street Journal. There is at least one two-pill version of Plan B that is marketed by Perrigo (PRGO). Actavis (ACT) has FDA approval for both a one-step and two-step version of Plan B, but it only markets the newer one-pill version. The Plan B drug, including one by Teva Pharmaceutical (TEVA), is sold without a prescription to people age 17 and older.

View Comments (0)